Source:
Highlights
"Head and neck cancer, like any cancer, is truly life-altering," says Christina Wicker, PhD, a postdoctoral fellow in the lab of Vinita Takiar.
"This drug compound has been well tolerated by patients and causes minimal side effects," she says.
Cancer eventually returns in up to half of the patients, Wicker says.
Washington: Researchers at the University of Cincinnati have tested a new combination therapy in animal models to see if they could find a way to make an already effective treatment even better. Since they`re using a Food and Drug Administration-approved drug to do it, this could help humans sooner than later.